切换至 "中华医学电子期刊资源库"

中华普通外科学文献(电子版) ›› 2008, Vol. 02 ›› Issue (04) : 291 -293. doi: 10.3877/cma.j.issn.1674-0793.2008.04.010

论著

开普拓、5-氟尿嘧啶、亚叶酸钙时辰化疗治疗大肠癌肝转移的临床观察
侯冰宗1, 周少朋1, 房思炼,1, 李霄凌1, 莫湘琼1   
  1. 1.519000 珠海,中山大学附属第五医院胃肠外科
  • 收稿日期:2008-04-25 出版日期:2008-08-01
  • 通信作者: 房思炼

Clinical study on chronomodulated chemotherapy of irinotecan combined with 5-FU and CF on colorectal carcinoma patients with hepatic metastasis

Bing-zong HOU1, Shao-peng ZHOU1, Si-lian FANG,1, Xiao-ling LI1, Xiang-qong MO1   

  1. 1.The Fifth Affiliated Hospital of Sun Yat-Sen University,Zhuhai 519000,China
  • Received:2008-04-25 Published:2008-08-01
  • Corresponding author: Si-lian FANG
引用本文:

侯冰宗, 周少朋, 房思炼, 李霄凌, 莫湘琼. 开普拓、5-氟尿嘧啶、亚叶酸钙时辰化疗治疗大肠癌肝转移的临床观察[J/OL]. 中华普通外科学文献(电子版), 2008, 02(04): 291-293.

Bing-zong HOU, Shao-peng ZHOU, Si-lian FANG, Xiao-ling LI, Xiang-qong MO. Clinical study on chronomodulated chemotherapy of irinotecan combined with 5-FU and CF on colorectal carcinoma patients with hepatic metastasis[J/OL]. Chinese Archives of General Surgery(Electronic Edition), 2008, 02(04): 291-293.

目的

观察开普拓、5-氟尿嘧啶、亚叶酸钙时辰化疗治疗大肠癌肝转移临床疗效及毒副作用。

方法

大肠癌手术后肝转移患者28例,随机分为A、B两组进行化疗,方案为:开普拓、5-氟尿嘧啶、亚叶酸钙,A组按时辰给药法治疗,B组按常规给药法治疗,按WHO标准观察两组患者的近期疗效及不良反应。

结果

A组有效率(CR+PR)为78.5%,B组为35.7%,A组与B组相比较差异有显著性意义(P<0.01),A组对化疗药物的毒副反应均较B组轻,A、B两组Ⅲ/Ⅳ度中性粒细胞减少、腹泻、脱发的发生率相比较差异均有显著性意义(P<0.05)。

结论

开普拓、5-氟尿嘧啶、亚叶酸钙时辰化疗作为一种新的给药方式进行大肠癌肝转移化疗,具有较好的临床疗效及较低的毒副反应。

Objective

To evaluate the clinical efficacy and the adverse drug reactions of chronomodulated chemotherapy of irinotecan(CPT-11)combined with 5-fluorouracil(5-FU)and calcium folinate(CF)on colorectal carcinoma patients with hepatic metastasis.

Methods

28 colorectal carcinoma patients with hepatic metastasis were divided into group A and B. group A were employed the chronomodulated chemotherapy of CPT-11 combined with 5-FU and CF procedure,while group B used the CPT-11combined with 5-FU and CF rountinly. The short term efficacy and adverse drug reactions were evaluated according to the standard by WHO.

Results

The higher percentages of clinical efficacy clinical efficacy(CR+PR)was A,78.5%vs B,35.7%and the lower percentages of adverse drug reactions occurred in group A (P<0.05).

Conclusion

Chronomodulated chemotherapy of CPT-11 combined with 5-FU and CF may be more effective and may cause the lower adverse drug reactions on colorectal carcinoma with hepatic metastasis.

表1 A、B两组患者的临床疗效比较(例)
表2 A、B两组患者化疗的毒副反应(例)
1
Mormont MC,Levi F.Cancer chronotherapy:principles,applictions,and perspectives.Cancer,2003,97(1):155-169.
2
Levi F, Zidani R, Misset JL. Randomised multi2centre trial of chronotherapywith oxaliplatin,fluorouracil,and folinic acid in metastatic colorectal cancer.Lancet,1997,350(9079):681-686.
3
Rothenberg ML, Eckardt JR, Kuhn JG, et al.Phase II trial of irinotecan in patients with progressive or rapidly recurrent colorectal cancer.J Clin Oncol,1996,14(4):1128-1135.
4
邓伟雄,葛轶群,林展雄,等.开普拓联合5-FU 治疗5-FU 耐药的晚期大肠癌.中国普通外科杂志,2004,13(9):644-646.
5
Saltz LB,Douillard JY,Pirotta N,et al.Irinotecan plus fluorouracil/leucovorin for metastatic colorectal cancer: a new survival standard.Oncologist, 2001,6(1):81-91.
6
Granda TG, D'Attino RM, Filipski E, et al.Circadian optimisation of irinotecan and oxaliplatin efficacy in mice with Glasgow osteosarcoma.Br J Cancer,2002,86(6):999-1005.
7
Giaecheti S,Zidani R,Goldwasser F,et al.Chronomodulated CPT-11.A pilot study.Proc Am Soc Clin Oncol,1999,18(996):259.
No related articles found!
阅读次数
全文
3
HTML PDF
最新录用 在线预览 正式出版 最新录用 在线预览 正式出版
0 0 0 0 0 3

  来源 其他网站
  次数 3
  比例 100%

摘要
16
最新录用 在线预览 正式出版
0 0 16
  来源 其他网站
  次数 16
  比例 100%